VIVID® CYP3A4 Red Screening Kit

Company
Invitrogen Corporation
Use
Enables fast measurements of interactions between drug candidates and cytochrome p450 enzymes.
Features
Will allow investigators to rapidly identify interactions of CYP450
NIH Contribution
Described antigen binding polypeptides that specifically bind to many human cytochrome p450s.
HHS Institute/Agency
NCI
Inventor(s)
H. Gelboin. F. Gonzalez
Year
1998
Tech Cat
Research Reagent

Request More Info

L-084-1998